Dalian BIO-CHEM Company Limited (SHA:603360)
China
· Delayed Price · Currency is CNY 27.30
+0.68 (2.55%)
Mar 10, 2026, 9:35 AM CST
Dalian BIO-CHEM Company Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 18,657 | 10,998 | 3,732 | 4,451 | 3,334 | 3,988 | Upgrade
|
| Market Cap Growth | 55.52% | 194.70% | -16.15% | 33.48% | -16.39% | -38.91% | Upgrade
|
| Enterprise Value | 19,597 | 10,736 | 3,361 | 4,263 | 3,506 | 3,790 | Upgrade
|
| Last Close Price | 26.62 | 15.55 | 5.09 | 5.73 | 4.25 | 4.78 | Upgrade
|
| PE Ratio | 86.51 | 31.86 | 11.37 | 11.06 | 13.31 | 17.99 | Upgrade
|
| Forward PE | 88.73 | 10.46 | 10.46 | 11.95 | 13.57 | 12.71 | Upgrade
|
| PS Ratio | 12.68 | 8.39 | 3.50 | 3.54 | 3.31 | 5.32 | Upgrade
|
| PB Ratio | 8.98 | 4.68 | 2.28 | 3.05 | 3.18 | 4.04 | Upgrade
|
| P/TBV Ratio | 16.25 | 7.74 | 2.34 | 3.14 | 3.48 | 4.46 | Upgrade
|
| P/FCF Ratio | 293.71 | 124.88 | 11.58 | 12.88 | - | 39.33 | Upgrade
|
| P/OCF Ratio | 151.89 | 67.48 | 9.58 | 9.27 | 23.48 | 18.94 | Upgrade
|
| EV/Sales Ratio | 13.31 | 8.19 | 3.15 | 3.39 | 3.49 | 5.06 | Upgrade
|
| EV/EBITDA Ratio | 53.20 | 23.16 | 7.64 | 8.25 | 9.93 | 12.78 | Upgrade
|
| EV/EBIT Ratio | 66.46 | 27.19 | 8.93 | 9.57 | 11.50 | 14.92 | Upgrade
|
| EV/FCF Ratio | 308.51 | 121.91 | 10.43 | 12.34 | - | 37.37 | Upgrade
|
| Debt / Equity Ratio | 0.54 | 0.24 | 0.09 | 0.09 | 0.32 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 3.04 | 1.22 | 0.34 | 0.25 | 0.96 | 1.01 | Upgrade
|
| Debt / FCF Ratio | 17.63 | 6.45 | 0.47 | 0.37 | - | 2.96 | Upgrade
|
| Net Debt / Equity Ratio | 0.18 | -0.04 | -0.27 | -0.20 | 0.04 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.00 | -0.22 | -1.02 | -0.56 | 0.13 | -0.15 | Upgrade
|
| Net Debt / FCF Ratio | 5.79 | -1.14 | -1.39 | -0.84 | -0.89 | -0.43 | Upgrade
|
| Asset Turnover | 0.52 | 0.47 | 0.58 | 0.73 | 0.65 | 0.57 | Upgrade
|
| Inventory Turnover | 1.47 | 1.33 | 2.69 | 3.35 | 3.80 | 3.47 | Upgrade
|
| Quick Ratio | 1.45 | 1.10 | 3.67 | 3.40 | 0.91 | 1.21 | Upgrade
|
| Current Ratio | 2.97 | 2.26 | 4.70 | 4.36 | 1.36 | 1.54 | Upgrade
|
| Return on Equity (ROE) | 12.74% | 18.00% | 21.20% | 32.06% | 24.58% | 21.94% | Upgrade
|
| Return on Assets (ROA) | 6.54% | 8.84% | 12.73% | 16.26% | 12.29% | 12.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.02% | 19.89% | 27.15% | 34.31% | 25.66% | 24.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.40% | 15.60% | 22.50% | 29.40% | 26.90% | 24.60% | Upgrade
|
| Earnings Yield | 1.16% | 3.14% | 8.80% | 9.04% | 7.51% | 5.56% | Upgrade
|
| FCF Yield | 0.34% | 0.80% | 8.64% | 7.77% | -1.49% | 2.54% | Upgrade
|
| Dividend Yield | 1.57% | 2.76% | 6.02% | 5.09% | - | 4.57% | Upgrade
|
| Payout Ratio | 151.44% | 64.77% | 63.00% | 1.61% | 63.48% | 50.92% | Upgrade
|
| Buyback Yield / Dilution | 0.42% | -2.04% | -0.64% | 0.30% | 3.01% | 0.52% | Upgrade
|
| Total Shareholder Return | 1.99% | 0.71% | 5.38% | 5.39% | 3.01% | 5.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.